Work

Validation of real-world event-free survival (rwEFS) in early-stage triple-negative breast cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.11166

Authors: Carole Berini, Jessica Paulus, Malcolm Charles, Zhaohui Su, Paul R. Conkling, Nina Balanchivadze, Jagadeswara Rao Earla, Amin Haiderali, Kaushal Desai

Institutions: Virginia Oncology Associates, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Merck

OpenAlex ID: W4410811356

Cites:

Cited by:

Related to: 10